Cardiovascular disease (CVD) risk assessment of HIV medication regimens using hematopoietic CD34+ progenitor cells

BACKGROUND: To determine the effects of integrase inhibitor (INSTI) in comparison with non-INSTI-based regimens such as non-nucleoside reverse transcriptase inhibitors (NNRTIs)-based regimens on cardiovascular disease (CVD) risk in HIV+ patients without overt history of CVD or diabetes, with normal...

Descripción completa

Detalles Bibliográficos
Autores principales: Elzarki, Adrian Farid, Nandula, Seshagiri Rao, Awal, Hassan, Simon, Gary L., Sen, Sabyasachi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900400/
https://www.ncbi.nlm.nih.gov/pubmed/35255964
http://dx.doi.org/10.1186/s13287-022-02775-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900400/
https://www.ncbi.nlm.nih.gov/pubmed/35255964
http://dx.doi.org/10.1186/s13287-022-02775-6

Ejemplares similares